Tricida, Inc.

(NASDAQ GS: TCDA)

Rigrodsky Law, P.A. is investigating potential claims against the officers and directors of Tricida, Inc. ("Tricida" or the "Company") on behalf of stockholders. A class action complaint has been filed against Tricida. The complaint alleges that defendants made materially false and misleading statements and omissions of material facts about Tricida's attempts to gain approval from the United States Food and Drug Administration ("FDA") for its lead investigational drug candidate, veverimer. Specifically, defendants made false and/or misleading statements and/or failed to disclose that: (i) Tricida's New Drug Application ("NDA") for veverimer was materially deficient; (ii) accordingly, it was foreseeably likely that the FDA would not accept the NDA for veverimer; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.

Join This Action

First Name*

Last Name*

Email Address*

Mailing Address*

City*

State/Province*

Zip/Postal Code*

Phone*

Number of Shares Purchased

Date(s) Shares Purchased

Purchase Price Per Share

Number of Shares Sold

Date(s) Shares Sold

Sale Price Per Share

Comments

Alternatively, you may upload your transactions using the upload button below or email them to info@rl-legal.com.

Select files

By signing and clicking the Submit button below, I hereby execute the Retention Agreement and, upon execution of the Retention Agreement by Rigrodsky Law, P.A., retain Rigrodsky Law, P.A. to bring a lawsuit on my behalf pursuant to the terms set forth in the Retention Agreement, which is incorporated herein by reference.*

Draw your signature below using your mouse* [Clear]

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

Date of signing: 04/26/2024

X Code

* Indicates a required field.